Stocks Health care HCIL

OTC · Health care

Hongchang International Co., Ltd (HCIL)

Hongchang International Co., Ltd brought in $18.2M of revenue over the twelve months to December 31, 2025, up 535.8% from a year earlier. Net income was $2.5M, a net margin of 13.7%. In fiscal 2024 capital spending exceeded operating cash flow by $11.4M. At December 31, 2025 it held $551.8K in cash against $7.1M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on February 13, 2026.

Watch HCIL in 60 seconds

What Hongchang International Co., Ltd does

Hongchang International Co., Ltd is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker HCIL.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where HCIL ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Hongchang International Co., Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 13, 2026
   Late quarterly report notice NT 10-Q
2. June 30, 2026
   Late annual report notice NT 10-K
3. February 13, 2026
   Quarterly report 10-Q · period to December 31, 2025Revenue rose 8,560% to $4M versus the same quarter last year; diluted EPS $0.00 versus -$0.00.
4. November 13, 2025
   Quarterly report 10-Q · period to September 30, 2025Revenue rose 323% to $3.5M versus the same quarter last year; diluted EPS $0.00 versus $0.00.
5. August 14, 2025
   Quarterly report 10-Q · period to June 30, 2025Revenue rose 94% to $3.8M versus the same quarter last year; diluted EPS $0.00 versus $0.00.
6. August 11, 2025
   Transition-period annual report 10-KT · period to March 31, 2025
7. May 13, 2025
   Bylaws or fiscal year changed 8-K
8. April 30, 2025
   Executive or director change 8-K
9. March 28, 2025
   Annual report 10-K · period to December 31, 2024Revenue rose 7.1% to $2.9M versus the prior year; diluted EPS $0.00 versus $0.00.
10. November 13, 2024
    Quarterly report 10-Q · period to September 30, 2024Revenue was $820.6K; diluted EPS was $0.00.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 29, 2026. Insider transactions on SEC

Insider trades

What the people running Hongchang International Co., Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HCIL

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 62,243,084 shares in total, about $6.6M at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HCIL

What does Hongchang International Co., Ltd do?

Hongchang International Co., Ltd is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker HCIL.

Is Hongchang International Co., Ltd profitable?

Yes. Over the twelve months to December 31, 2025 it reported net income of $2.5M on revenue of $18.2M, a net margin of 13.7%.

How much revenue does Hongchang International Co., Ltd make?

Over the twelve months to December 31, 2025 Hongchang International Co., Ltd reported revenue of $18.2M. That is 535.8% more than a year earlier.

When did Hongchang International Co., Ltd last report?

Its most recent periodic report is the quarterly report (10-Q) filed on February 13, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the late quarterly report notice from August 13, 2026.

Similar companies

Compare HCIL with

Compare HCIL with any company

Follow HCIL

Get an email when Hongchang International Co., Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Follow HCIL: get an email when it files

Where the numbers come from

Financial figures are the values Hongchang International Co., Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.